The application of GAS to decrease the activation of the KLK8-PAR1 signaling axis triggered by HG-PA is an innovative therapeutic approach to prevent the development and progression of DCM marked by cardiac fibrosis. The gene discussed is KLK8; the disease is familial dilated cardiomyopathy.